Form 4: Day One Biopharmaceuticals' General Counsel Adam Dubow Reports Stock Transactions
SEC Form 4 Filing
Adam Dubow, General Counsel of Day One Biopharmaceuticals, reports the acquisition and disposal of common stock and Restricted Stock Units (RSUs) related to tax liability coverage.
Summary
- On February 15, 2025, Adam Dubow, General Counsel of Day One Biopharmaceuticals, acquired common stock through the vesting of Restricted Stock Units (RSUs).
- Specifically, 2,962, 1,750, 3,687 and 3,687 shares were acquired through RSU conversions.
- On February 18, 2025, Dubow disposed of 4,646 shares of common stock at a weighted average price of $11.963 per share to cover tax liabilities associated with the RSU settlements.
- Following these transactions, Dubow directly owns 39,602 shares of Day One Biopharmaceuticals' common stock and holds rights to 55,313 additional shares through RSUs.
Sentiment
Score: 5
Explanation: The document reflects standard insider trading activity related to stock-based compensation and tax obligations, indicating a neutral sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors monitor these filings to understand management's perspective on the company's stock.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies, as mandated by the SEC.
- The transactions are typical for executives receiving stock-based compensation and selling shares to cover tax liabilities.
- Similar filings can be observed for executives at comparable biopharmaceutical companies such as BioMarin, Vertex, and Amgen.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the sale of shares, but it's primarily driven by tax obligations.
- Employees holding RSUs are indirectly affected as these transactions reflect the company's compensation structure.
Key Dates
| Date | Description |
|---|---|
| 11/15/2023 | RSUs vest as to 25% of the total award |
| 02/15/2025 | Date of RSU conversions and stock acquisitions. |
| 02/15/2025 | Quarterly installment vesting date for RSUs. |
| 02/18/2025 | Date of stock disposal for tax liability. |
| 02/21/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Beneficial Ownership, Restricted Stock Units, RSU, Adam Dubow, Day One Biopharmaceuticals, DAWN, Common Stock, General Counsel, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.